Table 1.
Disease | Species | STZ Injection Pattern | EGCG dose | Protective Mechanism | Reference |
---|---|---|---|---|---|
Diabetes | Rats | i.p. | 25 mg/kg | ↑SOD,↓MDA, ↓NO | Roghani and Baluchnejadmojarad, 2009 |
Rats | i.p. | 60 mg/kg | ↑SOD,↓MDA | Roghani and Baluchnejadmojarad, 2010 | |
Mice | i.p. | 100 mg/kg | ↑pancreatic islet mass, ↓iNOS | Song et al., 2003 | |
Rats | i.p. | 40 mg/kg | ↑SOD,↓nitrite, | Baluchnejadmojarad and Roghani, 2012 | |
Rats | i.p. | 2 g/L (in water) | ↓oxidative stress (8-OHdG) | Raposo et al., 2015 | |
Rats | i.p. | 7.6 mg/L (in water) | ↓MDA, ↑glutathione peroxidase | Mostafa et al., 2013 | |
Rats | i.p. | 100 mg/kg | ↓oxidative stress, ↓MDA, ↑MnSOD | Wu et al., 2017 | |
Rats | i.p. | 50–100 mg/kg | ↓oxidative stress | Yamabe et al., 2006 | |
Mice | i.p. | 100 mg/kg | ↓oxidative damage, ↑Nrf2 | Pan et al., 2017; Sun et al., 2017 | |
AD | Rats | i.p. | 40 mg/kg | ↑glutathione peroxidase, ↓reactive oxygen species, ↓NO production | Baluchnejadmojarad and Roghani, 2011 |
Rats | icv. | 10 mg/kg | ↑learning and memory, ↓malondialdehyde, ↓NO | Biasibetti et al., 2013 | |
(↑) Increase, (↓) Decrease for STZ + EGCG group vs. STZ group.